Stay updated on CABozantinib in NSCLC MET Clinical Trial

Sign up to get notified when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CABozantinib in NSCLC MET Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Padova, PD, Italy 35128 has been added and Padua, PD, Italy 35128 removed from the locations list.
    Difference
    0.0%
    Check dated 2026-04-09T07:55:15.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T19:52:06.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:37:41.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding notice and the prior Revision: v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-11T01:31:09.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now displays a site-wide funding status notice and has a version update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-03T23:25:01.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated metadata labels: 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new 'Revision: v3.4.0' tag. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were replaced.
    Difference
    0.2%
    Check dated 2026-01-27T20:04:04.000Z thumbnail image

Stay in the know with updates to CABozantinib in NSCLC MET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CABozantinib in NSCLC MET Clinical Trial page.